Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy
Advanced Science · 2024-07 · 11 (25)
DOI: 10.1002/advs.202305895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.04.2024. Verfasst von Qingbo Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Department of Cardiology, Sir Run Run Shaw Hospital, Zh…. Hauptthemen laut MEDLINE: Ferroptosis, Myocardial Infarction, Iron Chelating Agents, Disease Models, Animal. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Myocardial infarction (MI), a consequence of coronary artery occlusion, triggers the degradation of ferritin, resulting in elevated levels of free iron in the heart and thereby inducing ferroptosis. Targeting myocardial ferroptosis through the chelation of excess iron has therapeutic potential for MI treatment. However, iron chelation in post ischemic injury areas using conventional iron‐specific chelators is hindered by ineffective myocardial intracellular chelation, rapid clearance, and high systemic toxicity. A chitosan‐desferrioxamine nanosponge (CDNS) is designed by co‐crosslinking chitosan and deferoxamine through noncovalent gelation to address these challenges. This architecture facilitates direct iron chelation regardless of deferoxamine (DFO) release due to its sponge‐like porous hydrogel structure. Upon cellular internalization, CDNS can effectively chelate cellular iron and facilitate the efflux of captured iron, thereby inhibiting ferroptosis and associated oxidative stress and lipid peroxidation. In MI mouse models, myocardial injection of CDNS promotes sustainable retention and the suppression of ferroptosis in the infarcted heart. This intervention improves cardiac function and alleviates adverse cardiac remodeling post‐MI, leading to decreased oxidative stress and the promotion of angiogenesis due to ferroptosis inhibition by CDNS in the infarcted heart. This study reveals a nanosponge‐based nanomedicine targeting myocardial ferroptosis with efficient iron chelation and efflux, offering a promising MI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
- Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
- Qiushi Academy for Advanced Studies, Zhejiang University, Hangzhou, 310058, China.
ORCID-Profile: Yun Xiao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Lv, Q., Lin, J., Huang, H., Ma, B., Li, W., Chen, J., Wang, M., Wang, X., Fu, G., & Xiao, Y. (2024). Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy. Advanced Science, 11(25). https://doi.org/10.1002/advs.202305895
Vancouver
Lv Q, Lin J, Huang H, Ma B, Li W, Chen J, et al. Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy. Advanced Science. 2024;11(25). doi:10.1002/advs.202305895
BibTeX
@article{Lv2024,
author = {Lv, Qingbo and Lin, Jun and Huang, He and Ma, Boxuan and Li, Wujiao and Chen, Jiawen and Wang, Meihui and Wang, Xiaoyu and Fu, Guosheng and Xiao, Yun},
title = {Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {25},
doi = {10.1002/advs.202305895}
}
EUVIMED